Direct‐Acting Antivirals in Hepatitis C Virus‐Associated Diffuse Large B‐cell Lymphomas

BACKGROUND. International guidelines suggest hepatitis C virus (HCV) eradication by direct‐acting antivirals (DAAs) after first‐line immunochemotherapy (I‐CT) in patients with HCV‐positive diffuse large B‐cell lymphoma (DLBCL), although limited experiences substantiate this recommendation. Moreover,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Merli, Michele, Frigeni, Marco, Alric, Laurent, Visco, Carlo, Besson, Caroline, Mannelli, Lara, Di Rocco, Alice, Ferrari, Angela, Farina, Lucia, Pirisi, Mario, Piazza, Francesco, Loustaud‐Ratti, Véronique, Arcari, Annalisa, Marino, Dario, Sica, Antonello, Goldaniga, Maria, Rusconi, Chiara, Gentile, Massimo, Cencini, Emanuele, Benanti, Francesco, Rumi, Maria Grazia, Ferretti, Virginia Valeria, Grossi, Paolo, Gotti, Manuel, Sciarra, Roberta, Tisi, Maria Chiara, Cano, Isabel, Zuccaro, Valentina, Passamonti, Francesco, Arcaini, Luca
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley & Sons, Inc. 2018
Témata:
Hematologic Malignancies
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6693710/
https://ncbi.nlm.nih.gov/pubmed/30552159
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0331
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky